STORY CONTINUES BELOW THESE SALTWIRE VIDEOS - British drugmaker AstraZeneca said on Friday it has filed a legal challenge to critical aspects of a program that gives the Medicare health insurance plan the power to negotiate lower drug prices.
The drug price negotiation program is part of President Joe Biden's signature Inflation Reduction Act . The program faces several other court challenges, including from leading industry groups and other drug companies. ‍AstraZeneca said it was filing a legal challenge in a bid to"protect timely access to medicines for orphan indications" in the United States.